Signal return
+0.00%
Price move
-5.05%（$-9.02）
First included
2026-07-10
Inclusion price
$178.49
Latest brief price
$169.47
Methodology: each issue's direction is a live signal — long/short opens or holds a position, neutral means flat, and every direction change opens, flips, or closes it. Returns are direction-aware (a short gains when the price falls) and compound across positions from first observation to the latest issue. "Price move" is the stock's own raw change, shown separately. Neither represents actual portfolio performance.
Brief History (2 issues)
July 14, 2026NeutralRapid scan5/10$169.47-1.25%
Down 1.3% to $169.47 after a 10.9% weekly slide — no basing structure yet in this pharma pullback; sidelines
July 10, 2026NeutralDeep dive6/10$178.49-5.70%
A defensive mega-pharma below all its averages usually grinds sideways rather than bouncing; gap repair needs a fresh catalyst. Dividend and valuation set the floor, but there's no near-term entry signal.